Aurinia Pharmaceuticals Inc. (AUPH)
AUPH Stock Price Chart
Explore Aurinia Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze AUPH price movements and trends.
AUPH Company Profile
Discover essential business fundamentals and corporate details for Aurinia Pharmaceuticals Inc. (AUPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Sept 2014
Employees
130.00
Website
https://www.auriniapharma.comCEO
Peter S. Greenleaf
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
AUPH Financial Timeline
Browse a chronological timeline of Aurinia Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.17.
Earnings released on 31 Jul 2025
EPS came in at $0.16 falling short of the estimated $0.17 by -5.88%, while revenue for the quarter reached $70.01M , beating expectations by +3.40%.
Earnings released on 12 May 2025
EPS came in at $0.16 surpassing the estimated $0.08 by +100.00%, while revenue for the quarter reached $62.47M , missing expectations by -3.36%.
Earnings released on 27 Feb 2025
EPS came in at $0.09 surpassing the estimated $0.03 by +200.00%, while revenue for the quarter reached $59.87M , missing expectations by -3.18%.
Earnings released on 7 Nov 2024
EPS came in at $0.10 surpassing the estimated $0.02 by +566.67%, while revenue for the quarter reached $67.77M , beating expectations by +4.17%.
Earnings released on 1 Aug 2024
EPS came in at $0.02 surpassing the estimated $0.02 by +20.05%, while revenue for the quarter reached $57.19M , beating expectations by +3.89%.
Earnings released on 2 May 2024
EPS came in at -$0.03 surpassing the estimated -$0.17 by +82.35%, while revenue for the quarter reached $50.30M , beating expectations by +6.01%.
Earnings released on 15 Feb 2024
EPS came in at -$0.19 falling short of the estimated -$0.18 by -5.56%, while revenue for the quarter reached $45.10M , beating expectations by +1.45%.
Earnings released on 2 Nov 2023
EPS came in at -$0.09 surpassing the estimated -$0.17 by +47.06%, while revenue for the quarter reached $54.52M , beating expectations by +41.60%.
Earnings released on 3 Aug 2023
EPS came in at -$0.08 surpassing the estimated -$0.20 by +60.00%, while revenue for the quarter reached $41.49M , beating expectations by +8.77%.
Earnings released on 4 May 2023
EPS came in at -$0.18 surpassing the estimated -$0.24 by +25.00%, while revenue for the quarter reached $34.41M , beating expectations by +23.46%.
Earnings released on 28 Feb 2023
EPS came in at -$0.18 surpassing the estimated -$0.26 by +30.77%, while revenue for the quarter reached $28.44M , beating expectations by +2.38%.
Earnings released on 3 Nov 2022
EPS came in at -$0.06 surpassing the estimated -$0.18 by +66.67%, while revenue for the quarter reached $55.78M , beating expectations by +54.15%.
Earnings released on 4 Aug 2022
EPS came in at -$0.25 falling short of the estimated -$0.22 by -13.64%, while revenue for the quarter reached $28.19M , beating expectations by +4.25%.
Earnings released on 10 May 2022
EPS came in at -$0.27 falling short of the estimated -$0.26 by -3.85%, while revenue for the quarter reached $21.63M , beating expectations by +12.45%.
Earnings released on 28 Feb 2022
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $23.40M , beating expectations by +6.41%.
Earnings released on 3 Nov 2021
EPS came in at -$0.39 falling short of the estimated -$0.31 by -25.81%, while revenue for the quarter reached $14.67M , beating expectations by +36.57K%.
Earnings released on 5 Aug 2021
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%, while revenue for the quarter reached $6.62M , beating expectations by +16.45K%.
Earnings released on 6 May 2021
EPS came in at -$0.40 falling short of the estimated -$0.35 by -14.29%, while revenue for the quarter reached $914.00K , beating expectations by +2.19K%.
Earnings released on 24 Feb 2021
EPS came in at -$0.05 surpassing the estimated -$0.31 by +83.87%, while revenue for the quarter reached $50.03M , missing expectations by -37.98%.
Earnings released on 10 Nov 2020
EPS came in at -$0.28 falling short of the estimated -$0.22 by -27.27%, while revenue for the quarter reached $29.00K , beating expectations by +27.78%.
AUPH Stock Performance
Access detailed AUPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.